34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management

Tabs

Details

Event Information

Date:

Tuesday, August 21, 2018

Event Type:

Conference

Description:

The 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) was held August 22-26, 2018, in Prague, Czech Republic. More information on the conference can be found here.

A variety of Sentinel-related work was featured, including presentations, posters, and more. These materials have been made available below.

Event Materials:

Podium/Oral Presentations

Signal Detection using TreeScan with Drug Classes: Pilot Projects in Sentinel
Evaluation of Switching Patterns in FDA’s Sentinel System – A New Tool to Assess the Substitutability of Generic Drugs
Minor Differences, Major Consequences? Lessons Learned from Replication of a Claims-Based Drug Safety Assessment
Use of Multiple Sclerosis Drugs among Live Birth Pregnancies in the United States
Estimating “Optimal” Durations for Initial Opioid Analgesic Prescription Following Common Surgical Procedures
Extension of Disease Risk Score-Based Confounding Adjustments for Multiple Outcomes of Interest – An Empirical Evaluation
Validation of the Combined Comorbidity Score in the ICD-10 Era: Application to High-Risk Populations
Performance of a Distributed Regression Analysis Software and Workflow
Data Mining for Adverse Drug Events with a Propensity Score Matched Tree-Based Scan Statistic
Early Lessons on ICD-10-CM/PCS Transition in Claims-Based Drug Safety Assessments
Data-Mining for Adverse Events Using the Self-Controlled Tree-Temporal Scan Statistic
Validation of Transfusion Administrations Among Potential Transfusion-Related Acute Lung Injury (TRALI) Patients Included in the Sentinel Distributed Database
Using Time-Dependent Propensity Scores to Correct for Differential Depletion of Susceptibles when Estimating Hazard Ratios in Time-to-Event Data

Posters

Symposia

Workshops

Sequential and SequentialDesign: Tools For Prospective Sequential Medical Product Safety Surveillance

Additional Information

Information

Host:

International Society for Pharmacoepidemiology

Medical Product:

alemtuzumab, angiotensin-converting enzyme (ACE) inhibitor, blood transfusion, dabigatran, daclizumab, dalfampridine, dimethyl fumarate, fingolimod, glatiramer acetate, influenza vaccine, interferon beta-1A, interferon beta-1B, mitoxantrone, natalizumab, peginterferon beta-1a, teriflunomide, warfarin

Health Outcome(s):

acute myocardial infarction (AMI)

angioedema

cardiovascular death

myocardial infarction

neonatal enteroviral sepsis (NES)

spontaneous abortion (SAB)

transfusion-related acute lung injury (TRALI)

Search form

News & Events

34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management

Tabs